Medicalizing obesity: Individual, economic, and medical consequences

Virtual Mentor

Volumn 13, Issue 12, 2011, Pages 890-895

  Blackburn, George L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891740339     PISSN: 19377010     EISSN: None     Source Type: Journal    
DOI: 10.1001/virtualmentor.2011.13.12.pfor1-1112     Document Type: Review

References (31)

1. Sadler JZ, Jotterand F, Lee SC, Inrig S. Can medicalization be good? Situating medicalization within bioethics. Theor Med Bioeth. 2009;30(6):411-425.
2. Sadler, Jotterand, Lee, Inrig, 412.
3. Conrad P, Mackie T, Mehrotra A. Estimating the costs of medicalization. Soc Sci Med. 2010;70(12):1943-1947.
4. Fairman KA, Curtiss FR. Does medicalization of life imperil health? Expanding indications for diagnosis and treatment of chronic “disease”. J Manag Care Pharm. 2011;17(6):469-480.
5. Saarni SI, Anttila H, Saarni SE, et al. Ethical issues of obesity surgery-a health technology assessment. Obes Surg. 2011;21(9):1469-1476.
6. Giel KE, Thiel A, Teufel M, Mayer J, Zipfel S. Weight bias in work settings - a qualitative review. Obes Facts. 2010;3(1):33-40.
7. Cheskin LJ, Kahan S, Geller G. Weight-based stigma and physician bias. Virtual Mentor. 2010;12(4):258-262.
8. Puhl RM, Heuer CA. The stigma of obesity: a review and update. Obesity (Silver Spring). 2009;17(5):941-964.
9. Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res. 2001;9(12):788-805.
10. Schwartz MB, Chambliss HO, Brownell KD, Blair SN, Billington C. Weight bias among health professionals specializing in obesity. Obes Res. 2003;11(9):1033-1039.
11. Huizinga MM, Cooper LA, Bleich SN, Clark JM, Beach MC. Physician respect for patients with obesity. J Gen Intern Med. 2009;24(11):1236-1239.
12. Hebl MR, Xu J. Weighing the care: physicians’ reactions to the size of a patient. Int J Obes Relat Metab Disord. 2001;25(8):1246-1252.
13. Ogden J, Flanagan Z. Beliefs about the causes and solutions to obesity: a comparison of GPs and lay people. Patient Educ Couns. 2008;71(1):72-78.
14. de Vries J: The obesity epidemic: medical and ethical considerations. Sci Eng Ethics. 2007;13(1):55-67.
15. Ells LJ, Lang R, Shield JP, et al. Obesity and disability - a short review. Obes Rev. 2006;7(4):341-345.
16. Atlantis E, Baker M. Obesity effects on depression: systematic review of epidemiological studies. Int J Obes (Lond). 2008;32(6):881-891.
17. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008;16(6):1161-1177.
18. Allison, Downey, Atkinson, 1162.
19. Moynihan R, Cassels A. Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All into Patients. New York: Nation Books; 2005.
20. Moynihan R. Medicalization. A new deal on disease definition. BMJ. 2011;342:d2548.
21. Downey M, Still C, Sharma AM. Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find? Curr Opin Endocrinol Diabetes Obes. 2011;18(5):321-327.
22. Budetti PP. Market justice and US health care. JAMA. 2008;299(1):92-94.
23. Roy K, Miller M. Parity and the medicalization of addiction treatment. J Psychoactive Drugs. 2010;42(2):115-120.
24. World Health Organization. Obesity and overweight: fact sheet no. 311. http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed October 2, 2011.
25. American Association of Clinical Endocrinologists (AACE) declares obesity a disease state [news release]. Jacksonville, FL: American Association of Clinical Endocrinologists (AACE); July 29, 2011. http://media.aace.com/article_display.cfm?article_id=5075. Accessed October 2, 2011.
26. Non-communicable diseases deemed development challenge of “epidemic proportions” in political declaration adopted during landmark General Assembly meeting [news release]. New York: United Nations; September 19, 2011. http://www.un.org/News/Press/docs/2011/ga11138.doc.htm. Accessed October 2, 2011.
27. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes Relat Metab Disord. 2004;28(1):34-38.
28. Blackburn GL, Kanders BS. Medical evaluation and treatment of the obese patient with cardiovascular disease. Am J Cardiol. 1987;60(12):55G-58G.
29. National Heart Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases. Clinical guidelines on the Identification, Evaluation, And Treatment of Overweight and Obesity in Adults: The Evidence Report. National Institutes of Health; 1998. http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed November 16, 2011.
30. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell. 2004;116(2):337-350.
31. Rose N. Beyond medicalisation. Lancet. 2007;369(9562):700-702.